Get startedLog in
    Picture of Thalia Therapeutics logo

    THAT — Thalia Therapeutics News Story

    0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: N4 Pharma Says Unit Applied To U.S. FDA To Obtain Orphan Drug Designation For ECP105

    Picture of Thalia Therapeutics logoThalia Therapeutics
    03/07/2024 07:38
    July 3 (Reuters) - N4 Pharma PLC  N4P.L :
    * NANOGENICS SUBMITTED APPLICATION TO U.S. FDA TO OBTAIN
ORPHAN
DRUG DESIGNATION FOR ECP105
    * NANOGENICS FILED PATENT APPLICATION IN UK FOR NOVEL SIRNA

Source text for Eikon:  ID:nRSC8858Ua 
Further company coverage:  N4P.L 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Thalia Therapeutics

    See all news